Spectrascience New Stock Forecast - Naive Prediction
| SCIEDelisted Stock | USD 1.42 0.00 0.00% |
Spectrascience Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Spectrascience New stock prices and determine the direction of Spectrascience New's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Spectrascience New's historical fundamentals, such as revenue growth or operating cash flow patterns.
The value of RSI of Spectrascience New's stock price is about 64. This usually implies that the stock is rather overbought by investors at the present time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Spectrascience, making its price go up or down. Momentum 64
Buy Extended
Oversold | Overbought |
Using Spectrascience New hype-based prediction, you can estimate the value of Spectrascience New from the perspective of Spectrascience New response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Spectrascience New on the next trading day is expected to be 1.79 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 9.36. Spectrascience New after-hype prediction price | USD 1.42 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Spectrascience |
Spectrascience New Additional Predictive Modules
Most predictive techniques to examine Spectrascience price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Spectrascience using various technical indicators. When you analyze Spectrascience charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Spectrascience New Naive Prediction Price Forecast For the 27th of January
Given 90 days horizon, the Naive Prediction forecasted value of Spectrascience New on the next trading day is expected to be 1.79 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.05, and the sum of the absolute errors of 9.36.Please note that although there have been many attempts to predict Spectrascience Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Spectrascience New's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Spectrascience New Stock Forecast Pattern
| Backtest Spectrascience New | Spectrascience New Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Spectrascience New stock data series using in forecasting. Note that when a statistical model is used to represent Spectrascience New stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.1429 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1535 |
| MAPE | Mean absolute percentage error | 9.223372036854776E14 |
| SAE | Sum of the absolute errors | 9.3606 |
Predictive Modules for Spectrascience New
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Spectrascience New. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Spectrascience New After-Hype Price Density Analysis
As far as predicting the price of Spectrascience New at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Spectrascience New or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Spectrascience New, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Spectrascience New Estimiated After-Hype Price Volatility
In the context of predicting Spectrascience New's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Spectrascience New's historical news coverage. Spectrascience New's after-hype downside and upside margins for the prediction period are 1.16 and 1.68, respectively. We have considered Spectrascience New's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Spectrascience New is somewhat reliable at this time. Analysis and calculation of next after-hype price of Spectrascience New is based on 3 months time horizon.
Spectrascience New Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Spectrascience New is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Spectrascience New backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Spectrascience New, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.10 | 0.26 | 0.00 | 0.01 | 1 Events / Month | 1 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.42 | 1.42 | 0.00 |
|
Spectrascience New Hype Timeline
Spectrascience New is at this time traded for 1.42. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Spectrascience is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.1%. %. The volatility of related hype on Spectrascience New is about 419.35%, with the expected price after the next announcement by competition of 1.43. The company recorded a loss per share of 0.01. Spectrascience New had not issued any dividends in recent years. The entity had 1:100 split on the 18th of November 2003. Given the investment horizon of 90 days the next forecasted press release will be very soon. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.Spectrascience New Related Hype Analysis
Having access to credible news sources related to Spectrascience New's direct competition is more important than ever and may enhance your ability to predict Spectrascience New's future price movements. Getting to know how Spectrascience New's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Spectrascience New may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| STBV | Strategic Global Investments | 0.00 | 7 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BTTX | Better Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SNDZ | Sunridge International | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VIVE | Viveve Medical | 0.62 | 23 per month | 0.00 | 0.12 | 0.00 | 0.00 | 877.78 | |
| IMRSQ | IMRIS Inc | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CALA | Calithera Biosciences | 0.00 | 0 per month | 20.36 | 0.18 | 100.00 | (50.00) | 480.00 | |
| MSGP | Kenergy Scientific | 0.00 | 0 per month | 0.00 | 0.15 | 0.00 | 0.00 | 200.00 | |
| DMSI | Dermisonics | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IYXI | Inyx Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ARNI | Arno Therapeutics | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 100.00 |
Spectrascience New Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spectrascience New stock to make a market-neutral strategy. Peer analysis of Spectrascience New could also be used in its relative valuation, which is a method of valuing Spectrascience New by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Spectrascience New Market Strength Events
Market strength indicators help investors to evaluate how Spectrascience New stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spectrascience New shares will generate the highest return on investment. By undertsting and applying Spectrascience New stock market strength indicators, traders can identify Spectrascience New entry and exit signals to maximize returns.
Spectrascience New Risk Indicators
The analysis of Spectrascience New's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Spectrascience New's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting spectrascience stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.5387 | |||
| Semi Deviation | 0.844 | |||
| Standard Deviation | 1.17 | |||
| Variance | 1.37 | |||
| Downside Variance | 6.97 | |||
| Semi Variance | 0.7124 | |||
| Expected Short fall | (1.68) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Spectrascience New
The number of cover stories for Spectrascience New depends on current market conditions and Spectrascience New's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Spectrascience New is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Spectrascience New's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Spectrascience Stock
If you are still planning to invest in Spectrascience New check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spectrascience New's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |